CA1 pyramidal neurons: effects of Alzheimer (Culmone and Migliore 2012)


Culmone V, Migliore M. (2012). Progressive effect of beta amyloid peptides accumulation on CA1 pyramidal neurons: a model study suggesting possible treatments. Frontiers in computational neuroscience. 6 [PubMed]

See more from authors: Culmone V · Migliore M

References and models cited by this paper

Bentwich J et al. (2011). Beneficial effect of repetitive transcranial magnetic stimulation combined with cognitive training for the treatment of Alzheimer's disease: a proof of concept study. Journal of neural transmission (Vienna, Austria : 1996). 118 [PubMed]

Billings LM, Green KN, McGaugh JL, LaFerla FM. (2007). Learning decreases A beta*56 and tau pathology and ameliorates behavioral decline in 3xTg-AD mice. The Journal of neuroscience : the official journal of the Society for Neuroscience. 27 [PubMed]

Csicsvari J, Hirase H, Czurkó A, Mamiya A, Buzsáki G. (1999). Oscillatory coupling of hippocampal pyramidal cells and interneurons in the behaving Rat. The Journal of neuroscience : the official journal of the Society for Neuroscience. 19 [PubMed]

Eckert A et al. (2008). Soluble beta-amyloid leads to mitochondrial defects in amyloid precursor protein and tau transgenic mice. Neuro-degenerative diseases. 5 [PubMed]

Ferrante M, Blackwell KT, Migliore M, Ascoli GA. (2008). Computational models of neuronal biophysics and the characterization of potential neuropharmacological targets. Current medicinal chemistry. 15 [PubMed]

Gasparini S, Migliore M, Magee JC. (2004). On the initiation and propagation of dendritic spikes in CA1 pyramidal neurons. The Journal of neuroscience : the official journal of the Society for Neuroscience. 24 [PubMed]

Goedert M. (1987). Neuronal localization of amyloid beta protein precursor mRNA in normal human brain and in Alzheimer's disease. The EMBO journal. 6 [PubMed]

Good TA, Smith DO, Murphy RM. (1996). Beta-amyloid peptide blocks the fast-inactivating K+ current in rat hippocampal neurons. Biophysical journal. 70 [PubMed]

Hamos JE, DeGennaro LJ, Drachman DA. (1989). Synaptic loss in Alzheimer's disease and other dementias. Neurology. 39 [PubMed]

Hasselmo ME. (1997). A computational model of the progression of Alzheimer's disease. M.D. computing : computers in medical practice. 14 [PubMed]

Hines ML, Carnevale NT. (1997). The NEURON simulation environment. Neural computation. 9 [PubMed]

Horn D, Levy N, Ruppin E. (1996). Neuronal-based synaptic compensation: a computational study in Alzheimer's disease. Neural computation. 8 [PubMed]

Iwatsubo T et al. (1994). Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43). Neuron. 13 [PubMed]

Kamenetz F et al. (2003). APP processing and synaptic function. Neuron. 37 [PubMed]

Kim DY et al. (2007). BACE1 regulates voltage-gated sodium channels and neuronal activity. Nature cell biology. 9 [PubMed]

Kloskowska E, Malkiewicz K, Winblad B, Benedikz E, Bruton JD. (2008). APPswe mutation increases the frequency of spontaneous Ca2+-oscillations in rat hippocampal neurons. Neuroscience letters. 436 [PubMed]

Knobloch M, Mansuy IM. (2008). Dendritic spine loss and synaptic alterations in Alzheimer's disease. Molecular neurobiology. 37 [PubMed]

Kuchibhotla KV, Lattarulo CR, Hyman BT, Bacskai BJ. (2009). Synchronous hyperactivity and intercellular calcium waves in astrocytes in Alzheimer mice. Science (New York, N.Y.). 323 [PubMed]

LaFerla FM, Green KN, Oddo S. (2007). Intracellular amyloid-beta in Alzheimer's disease. Nature reviews. Neuroscience. 8 [PubMed]

MacLean JN et al. (2005). Activity-independent coregulation of IA and Ih in rhythmically active neurons. Journal of neurophysiology. 94 [PubMed]

Manczak M et al. (2006). Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression. Human molecular genetics. 15 [PubMed]

Mattson MP, Chan SL. (2001). Dysregulation of cellular calcium homeostasis in Alzheimer's disease: bad genes and bad habits. Journal of molecular neuroscience : MN. 17 [PubMed]

Megías M, Emri Z, Freund TF, Gulyás AI. (2001). Total number and distribution of inhibitory and excitatory synapses on hippocampal CA1 pyramidal cells. Neuroscience. 102 [PubMed]

Migliore M. (2003). On the integration of subthreshold inputs from Perforant Path and Schaffer Collaterals in hippocampal CA1 pyramidal neurons. Journal of computational neuroscience. 14 [PubMed]

Migliore M, Novara G, Tegolo D. (2008). Single neuron binding properties and the magical number 7. Hippocampus. 18 [PubMed]

Migliore M, Shepherd GM. (2002). Emerging rules for the distributions of active dendritic conductances. Nature reviews. Neuroscience. 3 [PubMed]

Moreira PI, Santos MS, Moreno A, Oliveira C. (2001). Amyloid beta-peptide promotes permeability transition pore in brain mitochondria. Bioscience reports. 21 [PubMed]

Morse TM, Carnevale NT, Mutalik PG, Migliore M, Shepherd GM. (2010). Abnormal Excitability of Oblique Dendrites Implicated in Early Alzheimer's: A Computational Study. Frontiers in neural circuits. 4 [PubMed]

Nagy Z et al. (1995). Relative roles of plaques and tangles in the dementia of Alzheimer's disease: correlations using three sets of neuropathological criteria. Dementia (Basel, Switzerland). 6 [PubMed]

Palop JJ, Mucke L. (2010). Amyloid-beta-induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks. Nature neuroscience. 13 [PubMed]

Parameshwaran K et al. (2007). Amyloid beta-peptide Abeta(1-42) but not Abeta(1-40) attenuates synaptic AMPA receptor function. Synapse (New York, N.Y.). 61 [PubMed]

Perez-Cruz C et al. (2011). Reduced spine density in specific regions of CA1 pyramidal neurons in two transgenic mouse models of Alzheimer's disease. The Journal of neuroscience : the official journal of the Society for Neuroscience. 31 [PubMed]

Plant LD et al. (2006). Amyloid beta peptide as a physiological modulator of neuronal 'A'-type K+ current. Neurobiology of aging. 27 [PubMed]

Ponomareva NV, Korovaitseva GI, Rogaev EI. (2008). EEG alterations in non-demented individuals related to apolipoprotein E genotype and to risk of Alzheimer disease. Neurobiology of aging. 29 [PubMed]

Reddy PH, Beal MF. (2008). Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease. Trends in molecular medicine. 14 [PubMed]

Rensink AA, de Waal RM, Kremer B, Verbeek MM. (2003). Pathogenesis of cerebral amyloid angiopathy. Brain research. Brain research reviews. 43 [PubMed]

Rowan M. (2012). Information-selectivity of Beta-amyloid pathology in an associative memory model. Frontiers in computational neuroscience. 6 [PubMed]

Rui Y et al. (2006). Acute effect of beta amyloid on synchronized spontaneous Ca2+ oscillations in cultured hippocampal networks. Cell biology international. 30 [PubMed]

Ruppin E, Reggia JA. (1995). A neural model of memory impairment in diffuse cerebral atrophy. The British journal of psychiatry : the journal of mental science. 166 [PubMed]

Sato S et al. (2008). Spatial learning impairment, enhanced CDK5/p35 activity, and downregulation of NMDA receptor expression in transgenic mice expressing tau-tubulin kinase 1. The Journal of neuroscience : the official journal of the Society for Neuroscience. 28 [PubMed]

Schenk D et al. (1999). Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature. 400 [PubMed]

Selkoe DJ. (1999). Translating cell biology into therapeutic advances in Alzheimer's disease. Nature. 399 [PubMed]

Shankar GM et al. (2007). Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. The Journal of neuroscience : the official journal of the Society for Neuroscience. 27 [PubMed]

Snyder EM et al. (2005). Regulation of NMDA receptor trafficking by amyloid-beta. Nature neuroscience. 8 [PubMed]

Terry RD. (2000). Cell death or synaptic loss in Alzheimer disease. Journal of neuropathology and experimental neurology. 59 [PubMed]

Terry RD et al. (1991). Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Annals of neurology. 30 [PubMed]

Texidó L, Martín-Satué M, Alberdi E, Solsona C, Matute C. (2011). Amyloid ß peptide oligomers directly activate NMDA receptors. Cell calcium. 49 [PubMed]

Wei W et al. (2010). Amyloid beta from axons and dendrites reduces local spine number and plasticity. Nature neuroscience. 13 [PubMed]

Zou X, Coyle D, Wong-Lin K, Maguire L. (2011). Computational study of hippocampal-septal theta rhythm changes due to ß-amyloid-altered ionic channels. PloS one. 6 [PubMed]

References and models that cite this paper

Migliore M, Tegolo D, Spera E, Unsworth N. (2016). On the cellular mechanisms underlying working memory capacity in humans Neural Network World. 4

Romani A et al. (2013). Computational modeling of the effects of amyloid-beta on release probability at hippocampal synapses. Frontiers in computational neuroscience. 7 [PubMed]

This website requires cookies and limited processing of your personal data in order to function. By continuing to browse or otherwise use this site, you are agreeing to this use. See our Privacy policy and how to cite and terms of use.